ARTICLE | Company News
Forma Therapeutics, Boehringer Ingelheim deal
June 22, 2015 7:00 AM UTC
Forma received undisclosed milestone payments from Boehringer under a 2012 deal to develop and discover small molecules against “oncology-relevant” protein-protein interactions. The Boehringer payment...